NEW YORK(GenomeWeb) – OncoDNA announced on Wednesday that it has finalized a South Korean distribution agreement with Eone-Diagnomics Genome Center (EDGC).

Under the terms of the agreement, EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other cancer-related tests. Korean physicians will have access to clinically relevant interpretations of test results using the OncoShare web platform.

The OncoDEEP Dx is a 50-gene next-generation sequencing-based diagnostic test that runs on Life Technologies' Ion Torrent instrument.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.